MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-16-2026
Meridian Bioscience ROA Ratio 2011-2026 | VIVO
Annual ROA Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.17 | 15.88 | 11.4 | 7.49 | 3.22 | 2.52 | 2.49 | 4.85 | 4.47 | 4.2 | 5.25 | 4.23 | 3.9 | 5.72 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.88 | 2.49 | 6.06 |
Quarterly ROA Ratio Meridian Bioscience
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.54 | 1.33 | 11.21 | 15.4 | 15.29 | 18.26 | 21.24 | 25.18 | 22.12 | 16.64 | 11.16 | 6.18 | 6.04 | 8.45 | 10.86 | 11.97 | 11.25 | 10.51 | 9.77 | 7.18 | 8.8 | 8.81 | 8.82 | 12.15 | 11.97 | 14.23 | 16.49 | 18.13 | 20.26 | 19.95 | 19.63 | 19.5 | 19.63 | 19.42 | 19.22 | 20.22 | 20.61 | 21.75 | 22.89 | 22.36 | 22.27 | 21.12 | 19.97 | 18.89 | 17.42 | 17.04 | 17.11 | 4.62 | 3.86 | 4.3 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.18 | -8.54 | 14.46 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 202.18 | -0.43 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 88.24 | -0.35 % | $ 4.13 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 3.78 | -11.89 % | $ 5.03 M | USA |
 |
Fulgent Genetics
FLGT
|
-4.99 | $ 18.35 | -1.77 % | $ 565 M | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 20.66 | -0.19 % | $ 599 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-20.67 | $ 129.82 | -1.37 % | $ 16.3 B | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.58 | -1.56 % | $ 6.99 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 24.08 | 4.83 % | $ 1.28 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
12.79 | $ 166.89 | 3.68 % | $ 25.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.41 | $ 147.72 | 1.05 % | $ 11.6 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 154.47 | 2.03 % | $ 23.8 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-83.11 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
8.6 | $ 18.31 | -2.55 % | $ 410 M | USA |
 |
Natera
NTRA
|
-8.68 | $ 216.97 | 2.31 % | $ 29.7 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 104.67 | 0.14 % | $ 7.06 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 188.47 | 0.51 % | $ 9.34 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-69.69 | $ 1.32 | 0.76 % | $ 396 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 467.5 | 0.03 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 4.32 | -0.23 % | $ 400 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 9.79 | 2.09 % | $ 874 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 26.69 | 0.87 % | $ 25.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 7.24 | 0.84 % | $ 302 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.0 | -2.44 % | $ 4.59 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 80.79 | 6.07 % | $ 4.83 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 265.03 | -0.42 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 473.72 | 1.03 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.68 | 4.18 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.3 | 2.2 % | $ 2.02 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |